发现2-芳基喹唑啉衍生物作为一类新型的凋亡信号调节激酶1（ASK1）抑制剂。
Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.
作者信息
Monastyrskyi Andrii, Bayle Simon, Quereda Victor, Grant Wayne, Cameron Michael, Duckett Derek, Roush William
机构信息
Department of Chemistry, Scripps Florida, 130 Scripps Way, Jupiter, FL 33458, United States.
Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, FL 33458, United States.
出版信息
Bioorg Med Chem Lett. 2018 Feb 1;28(3):400-404. doi: 10.1016/j.bmcl.2017.12.026. Epub 2017 Dec 13.
Abstract
The development of a new series of apoptosis signal-regulating kinase 1 (ASK1) inhibitors is described. Starting from purine, pyrimidine and quinazoline scaffolds identified by high throughput screening, we used tools of structure-based drug design to develop a series of potent kinase inhibitors, including 2-arylquinazoline derivatives 12 and 23, with submicromolar inhibitory activities against ASK1. Kinetic analysis demonstrated that the 2-arylquinazoline scaffold ASK1 inhibitors described herein are ATP competitive.
摘要
本文描述了一系列新型凋亡信号调节激酶1（ASK1）抑制剂的研发情况。从通过高通量筛选确定的嘌呤、嘧啶和喹唑啉骨架出发，我们运用基于结构的药物设计工具，开发了一系列强效激酶抑制剂，包括2-芳基喹唑啉衍生物12和23，它们对ASK1具有亚微摩尔级别的抑制活性。动力学分析表明，本文所述的2-芳基喹唑啉骨架ASK1抑制剂具有ATP竞争性。
相似文献
1
Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.发现2-芳基喹唑啉衍生物作为一类新型的凋亡信号调节激酶1（ASK1）抑制剂。
Bioorg Med Chem Lett. 2018 Feb 1;28(3):400-404. doi: 10.1016/j.bmcl.2017.12.026. Epub 2017 Dec 13.
2
Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.设计并评价咪唑并[1,2-a]吡啶类化合物作为新型强效 ASK1 抑制剂。
Bioorg Med Chem Lett. 2012 Dec 15;22(24):7326-9. doi: 10.1016/j.bmcl.2012.10.084. Epub 2012 Oct 23.
3
Rational design of apoptosis signal-regulating kinase 1 inhibitors: discovering novel structural scaffold.凋亡信号调节激酶1抑制剂的合理设计：发现新型结构骨架
Eur J Med Chem. 2013 Mar;61:104-15. doi: 10.1016/j.ejmech.2012.09.022. Epub 2012 Sep 21.
4
ASK1 pharmacophore model derived from diverse classes of inhibitors.源自不同类型抑制剂的ASK1药效团模型。
Bioorg Med Chem Lett. 2014 Sep 15;24(18):4418-4423. doi: 10.1016/j.bmcl.2014.08.011. Epub 2014 Aug 12.
5
Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors.设计、合成及生物评价 1H-吲唑衍生物作为新型 ASK1 抑制剂。
Eur J Med Chem. 2021 Aug 5;220:113482. doi: 10.1016/j.ejmech.2021.113482. Epub 2021 Apr 20.
6
Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors.理性设计高效且选择性的凋亡信号调节激酶 1（ASK1）抑制剂。
Eur J Med Chem. 2018 Feb 10;145:606-621. doi: 10.1016/j.ejmech.2017.12.041. Epub 2017 Dec 15.
7
Discovery and development of ASK1 inhibitors.ASK1抑制剂的发现与开发。
Prog Med Chem. 2020;59:101-179. doi: 10.1016/bs.pmch.2020.02.001. Epub 2020 Apr 22.
8
Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy.使用综合先导优化策略进行新型ASK1抑制剂的基于结构的药物设计。
Bioorg Med Chem Lett. 2017 Apr 15;27(8):1709-1713. doi: 10.1016/j.bmcl.2017.02.079. Epub 2017 Mar 2.
9
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation .发现强效、选择性且可穿透血脑屏障的凋亡信号调节激酶 1（ASK1）抑制剂，可调节脑炎症。
J Med Chem. 2021 Oct 28;64(20):15402-15419. doi: 10.1021/acs.jmedchem.1c01458. Epub 2021 Oct 15.
10
Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors.发现具有双氧代环的 6-取代 4-苯胺基喹唑啉类化合物作为新型 EGFR 酪氨酸激酶抑制剂。
Bioorg Med Chem Lett. 2012 Sep 15;22(18):5870-5. doi: 10.1016/j.bmcl.2012.07.079. Epub 2012 Jul 31.
引用本文的文献
1
Discovery of Novel Pyridin-2-yl Urea Inhibitors Targeting ASK1 Kinase and Its Binding Mode by Absolute Protein-Ligand Binding Free Energy Calculations.通过绝对蛋白质-配体结合自由能计算发现靶向ASK1激酶的新型吡啶-2-基脲抑制剂及其结合模式。
Int J Mol Sci. 2025 Feb 12;26(4):1527. doi: 10.3390/ijms26041527.
本文引用的文献
1
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure.基于结构的ASK1抑制剂设计：作为心力衰竭潜在治疗药物
ACS Med Chem Lett. 2017 Feb 8;8(3):316-320. doi: 10.1021/acsmedchemlett.6b00481. eCollection 2017 Mar 9.
2
Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy.使用综合先导优化策略进行新型ASK1抑制剂的基于结构的药物设计。
Bioorg Med Chem Lett. 2017 Apr 15;27(8):1709-1713. doi: 10.1016/j.bmcl.2017.02.079. Epub 2017 Mar 2.
3
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.ASK1 抑制剂可阻止 Nos3 缺陷型小鼠糖尿病肾病的进展。
Diabetes. 2015 Nov;64(11):3903-13. doi: 10.2337/db15-0384. Epub 2015 Jul 15.
4
Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury.凋亡信号调节激酶1抑制剂可预防对乙酰氨基酚诱导的肝损伤。
Toxicol Appl Pharmacol. 2015 Jul 1;286(1):1-9. doi: 10.1016/j.taap.2015.03.019. Epub 2015 Mar 25.
5
Design of a phase 2 clinical trial of an ASK1 inhibitor, GS-4997, in patients with diabetic kidney disease.ASK1抑制剂GS-4997用于糖尿病肾病患者的2期临床试验设计
Nephron. 2015;129(1):29-33. doi: 10.1159/000369152. Epub 2014 Dec 17.
6
Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology.利用AlphaScreen技术开发一种用于发现ASK1信号体抑制剂的与高通量筛选兼容的检测方法。
Assay Drug Dev Technol. 2014 May;12(4):229-37. doi: 10.1089/adt.2013.558.
7
Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.开发具有高选择性的酪蛋白激酶 1δ/1ε（CK1δ/ε）抑制剂，具有强大的抗增殖特性。
Bioorg Med Chem Lett. 2013 Aug 1;23(15):4374-80. doi: 10.1016/j.bmcl.2013.05.075. Epub 2013 May 31.
8
Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design.ASK1 抑制剂复合物的晶体结构为基于结构的药物设计提供了一个平台。
Protein Sci. 2013 Aug;22(8):1071-7. doi: 10.1002/pro.2298. Epub 2013 Jul 3.
9
Inhibition of apoptosis signal-regulating kinase 1 reduces myocardial ischemia-reperfusion injury in the mouse.抑制凋亡信号调节激酶 1 可减少小鼠心肌缺血再灌注损伤。
J Am Heart Assoc. 2012 Oct;1(5):e002360. doi: 10.1161/JAHA.112.002360. Epub 2012 Oct 25.
10
Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.设计并评价咪唑并[1,2-a]吡啶类化合物作为新型强效 ASK1 抑制剂。
Bioorg Med Chem Lett. 2012 Dec 15;22(24):7326-9. doi: 10.1016/j.bmcl.2012.10.084. Epub 2012 Oct 23.
Zotero 插件